Metastatic castration resistant prostate cancer: Updates from ASCO 2019
Dr Neal Shore, Dr Joaquin Mateo and Prof Karim Fizazi
7 Jun 2019
Prostate cancer updates: TITAN and ENZAMET
Prof Ian Davis and Prof Axel Merseburger
3 Jun 2019
Clinical updates for metastatic hormone sensitive prostate cancer at ASCO 2019
Prof Rob Jones, Prof Nick James, Prof Ian Davis, Prof Axel Merseburger
3 Jun 2019
Metastatic bladder cancer: Current practice and latest data from ASCO 2019
Dr Andrea Necchi, Dr Petros Grivas, Prof Arlene Siefker-Radtke, Prof Rob Jones
3 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
3 Jun 2019
Targeting agent enfortumab vedotin a novel treatment for patients with advanced ...
Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA
3 Jun 2019
New agent targeting Nectin-4 produces responses in nearly half of patients with ...
Prof Daniel Petrylak - Yale Cancer Center, New Haven, USA
3 Jun 2019
Novel therapies in the treatment of bladder cancer
Dr Petros Grivas and Dr Andrea Necchi
3 Jun 2019
Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer wi...
Prof Arnaud Mejean - Paris Descartes University, Paris, France
3 Jun 2019
Enzalutamide as treatment for men with mHSPC who have received testosterone supp...
Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
2 Jun 2019
Enzalutamide improves survival for men with metastatic hormone-sensitive prostat...
Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
2 Jun 2019
Comment: Using enzalutamide will allow patients to avoid chemotherapy and steroi...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA
2 Jun 2019
